Roivant Sciences Ltd. (ROIV) has 35 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $155.6M. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 16, 2026 | MANCHESTER KEITH S Director | $0 | 15,585 | +92% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | Gold Daniel Allen Director | $0 | 15,585 | +92% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | Oren Ilan Director | $0 | 15,585 | +92% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | MOMTAZEE JAMES C Director | $0 | 15,585 | +92% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | Epperly Melissa B, Director | $0 | 15,585 | +92% | No | |
|
|
||||||
Showing the 5 most recent of 35 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free